Jason B. B. Fleming, MD (he/him/his)

GI Oncology
Moffitt Cancer Center

Jason B. Fleming is the Department Chair and Program Leader of Gastrointestinal Oncology at H. Lee Moffitt Cancer Center. In 2017, Dr. Fleming was recruited to Moffitt from the University of Texas MD Anderson Cancer Center in Houston where he was a professor with tenure. Throughout his career, Dr. Fleming’s clinical and research efforts have focused on uncovering the biology of pancreatic cancer and using this knowledge to develop effective treatments to help patients. At Moffitt, Dr. Fleming leads an outstanding multispecialty team that works together to investigate, detect, and treat patients with all types of gastrointestinal cancer.

Poster(s):

• E227: Characterizing Conditional 90-Day Mortality and Associated Risk Factors Following Hepatobiliary and Pancreatic Cancer Surgery

• E255: The Impact of Neighborhood Socioeconomic Deprivation on Treatment for Resectable Pancreatic Cancer Patients in Florida: An Incidence-Based Retrospective Cohort Study

• E277: The Role of Neighborhood Socioeconomic Deprivation on Overall Survival for Stage I/II Hepatocellular Carcinoma Patients in Florida: An Incidence-Based Retrospective Cohort Study

• E280: The Association of Neighborhood Socioeconomic Deprivation and Treatment for Stage I/II Hepatocellular Carcinoma in Florida: An Incidence-Based Retrospective Cohort Study

• E401: Engagement, Perception, and Knowledge of Multidisciplinary Tumor Boards: A Patient’s Perspective

• E463: Characterizing Conditional 90-Day Mortality and Associated Risk Factors After Discharge from Complex Esophageal and Gastric Cancer Surgery

• E472: Defining the relationship between hospital surgical volume and hospital delivery of multimodal treatment for gastroesophageal adenocarcinoma: a retrospective cohort study.